Barreiras ao acesso à cannabis medicinal na Colômbia. Uma revisão narrativa

Introduction: In Colombia, since 2017, the medical cannabis market has been regulated; however, there are gaps between the standard, availability and access of patients to pharmaceutical products with cannabis derivatives, approved by the regulatory body and that meet quality standards. Objective: to carry out a narrative synthesis to identify elements that could be affecting patients' access to medicines with medicinal cannabis derivatives. Methodology: a nar-rative review was carried out consisting of five phases: I) bibliographic search, II) review by title and abstract, III) full text review and IV) selection of references and V) descriptive analysis. Results: individual barriers to access were identified such as low purchasing power in patients, myths and moral connotations that marijuana has on the part of the general population and doctors, and the lack of training of the latter. On the other hand, at the institutional and health systems level, difficulties were detected in the procedures to access treatments and poor availability of medicines. Conclusions: the findings offer an approach to proposing solutions and alternatives for structuring public health policies that guarantee access to cannabis-derived medicines for patients who require them.